RNA expression of complement regulatory proteins in human brain tumors

The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer letters 1994-11, Vol.86 (2), p.143-149
Hauptverfasser: Shinoura, Nobusada, Heffelfinger, Sue C., Miller, Maryann, Shamraj, Olga I., Miura, Nam-Ho C., Larson, Jeffrey J., DeTribolet, Nicolet, Warnick, Ronald E., Tew, John J., Menon, Anil G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 149
container_issue 2
container_start_page 143
container_title Cancer letters
container_volume 86
creator Shinoura, Nobusada
Heffelfinger, Sue C.
Miller, Maryann
Shamraj, Olga I.
Miura, Nam-Ho C.
Larson, Jeffrey J.
DeTribolet, Nicolet
Warnick, Ronald E.
Tew, John J.
Menon, Anil G.
description The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues.
doi_str_mv 10.1016/0304-3835(94)90072-8
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76856748</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0304383594900728</els_id><sourcerecordid>76856748</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-268f5a65b28fbd47d2f8fae848e9ff50cdd2f7c8a66a93f045589507de4e149a3</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRaq3-A4UcRPQQ3ST7eRFKsSoUBdHzst3M6kqSrbuJ2H9vYkuPnmaY95lheBA6zfB1hjN2gwtM0kIU9FKSK4kxz1Oxh8aZ6BsuBd5H4x1yiI5i_MQYU8LpCI04zZnk-RjNX56mCfysAsTofJN4mxhfryqooWmTAO9dpVsf1skq-BZcExPXJB9drZtkGXTft13tQzxGB1ZXEU62dYLe5nevs4d08Xz_OJsuUlMI1qY5E5ZqRpe5sMuS8DK3wmoQRIC0lmJT9hNuhGZMy8JiQqmQFPMSCGRE6mKCLjZ3-3e-Ooitql00UFW6Ad9FxZmgjBPRg2QDmuBjDGDVKrhah7XKsBr0qcGNGtwoSdSfPjWsnW3vd8sayt3S1lefn29zHY2ubNCNcXGHFUUmJME9drvBoHfx7SCoaBw0BkoXwLSq9O7_P34B9gSMBA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76856748</pqid></control><display><type>article</type><title>RNA expression of complement regulatory proteins in human brain tumors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Shinoura, Nobusada ; Heffelfinger, Sue C. ; Miller, Maryann ; Shamraj, Olga I. ; Miura, Nam-Ho C. ; Larson, Jeffrey J. ; DeTribolet, Nicolet ; Warnick, Ronald E. ; Tew, John J. ; Menon, Anil G.</creator><creatorcontrib>Shinoura, Nobusada ; Heffelfinger, Sue C. ; Miller, Maryann ; Shamraj, Olga I. ; Miura, Nam-Ho C. ; Larson, Jeffrey J. ; DeTribolet, Nicolet ; Warnick, Ronald E. ; Tew, John J. ; Menon, Anil G.</creatorcontrib><description>The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/0304-3835(94)90072-8</identifier><identifier>PMID: 7526972</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Antigens, CD - genetics ; Astrocytoma - genetics ; Base Sequence ; Biological and medical sciences ; Brain Neoplasms - genetics ; Brain tumor ; CD55 Antigens ; CD59 ; CD59 Antigens ; Clusterin ; Complement Inactivator Proteins - genetics ; Complement regulatory protein ; Glycoproteins ; Humans ; Medical sciences ; Membrane Cofactor Protein ; Membrane Glycoproteins - genetics ; Meningioma - genetics ; Molecular Chaperones ; Molecular Sequence Data ; Neurology ; RNA - analysis ; SP40,40 ; Tumor Cells, Cultured ; Tumors of the nervous system. Phacomatoses ; Vitronectin</subject><ispartof>Cancer letters, 1994-11, Vol.86 (2), p.143-149</ispartof><rights>1994</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-268f5a65b28fbd47d2f8fae848e9ff50cdd2f7c8a66a93f045589507de4e149a3</citedby><cites>FETCH-LOGICAL-c386t-268f5a65b28fbd47d2f8fae848e9ff50cdd2f7c8a66a93f045589507de4e149a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0304383594900728$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3318940$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7526972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shinoura, Nobusada</creatorcontrib><creatorcontrib>Heffelfinger, Sue C.</creatorcontrib><creatorcontrib>Miller, Maryann</creatorcontrib><creatorcontrib>Shamraj, Olga I.</creatorcontrib><creatorcontrib>Miura, Nam-Ho C.</creatorcontrib><creatorcontrib>Larson, Jeffrey J.</creatorcontrib><creatorcontrib>DeTribolet, Nicolet</creatorcontrib><creatorcontrib>Warnick, Ronald E.</creatorcontrib><creatorcontrib>Tew, John J.</creatorcontrib><creatorcontrib>Menon, Anil G.</creatorcontrib><title>RNA expression of complement regulatory proteins in human brain tumors</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues.</description><subject>Antigens, CD - genetics</subject><subject>Astrocytoma - genetics</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>Brain Neoplasms - genetics</subject><subject>Brain tumor</subject><subject>CD55 Antigens</subject><subject>CD59</subject><subject>CD59 Antigens</subject><subject>Clusterin</subject><subject>Complement Inactivator Proteins - genetics</subject><subject>Complement regulatory protein</subject><subject>Glycoproteins</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Membrane Cofactor Protein</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Meningioma - genetics</subject><subject>Molecular Chaperones</subject><subject>Molecular Sequence Data</subject><subject>Neurology</subject><subject>RNA - analysis</subject><subject>SP40,40</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors of the nervous system. Phacomatoses</subject><subject>Vitronectin</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRaq3-A4UcRPQQ3ST7eRFKsSoUBdHzst3M6kqSrbuJ2H9vYkuPnmaY95lheBA6zfB1hjN2gwtM0kIU9FKSK4kxz1Oxh8aZ6BsuBd5H4x1yiI5i_MQYU8LpCI04zZnk-RjNX56mCfysAsTofJN4mxhfryqooWmTAO9dpVsf1skq-BZcExPXJB9drZtkGXTft13tQzxGB1ZXEU62dYLe5nevs4d08Xz_OJsuUlMI1qY5E5ZqRpe5sMuS8DK3wmoQRIC0lmJT9hNuhGZMy8JiQqmQFPMSCGRE6mKCLjZ3-3e-Ooitql00UFW6Ad9FxZmgjBPRg2QDmuBjDGDVKrhah7XKsBr0qcGNGtwoSdSfPjWsnW3vd8sayt3S1lefn29zHY2ubNCNcXGHFUUmJME9drvBoHfx7SCoaBw0BkoXwLSq9O7_P34B9gSMBA</recordid><startdate>19941111</startdate><enddate>19941111</enddate><creator>Shinoura, Nobusada</creator><creator>Heffelfinger, Sue C.</creator><creator>Miller, Maryann</creator><creator>Shamraj, Olga I.</creator><creator>Miura, Nam-Ho C.</creator><creator>Larson, Jeffrey J.</creator><creator>DeTribolet, Nicolet</creator><creator>Warnick, Ronald E.</creator><creator>Tew, John J.</creator><creator>Menon, Anil G.</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19941111</creationdate><title>RNA expression of complement regulatory proteins in human brain tumors</title><author>Shinoura, Nobusada ; Heffelfinger, Sue C. ; Miller, Maryann ; Shamraj, Olga I. ; Miura, Nam-Ho C. ; Larson, Jeffrey J. ; DeTribolet, Nicolet ; Warnick, Ronald E. ; Tew, John J. ; Menon, Anil G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-268f5a65b28fbd47d2f8fae848e9ff50cdd2f7c8a66a93f045589507de4e149a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Antigens, CD - genetics</topic><topic>Astrocytoma - genetics</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>Brain Neoplasms - genetics</topic><topic>Brain tumor</topic><topic>CD55 Antigens</topic><topic>CD59</topic><topic>CD59 Antigens</topic><topic>Clusterin</topic><topic>Complement Inactivator Proteins - genetics</topic><topic>Complement regulatory protein</topic><topic>Glycoproteins</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Membrane Cofactor Protein</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Meningioma - genetics</topic><topic>Molecular Chaperones</topic><topic>Molecular Sequence Data</topic><topic>Neurology</topic><topic>RNA - analysis</topic><topic>SP40,40</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors of the nervous system. Phacomatoses</topic><topic>Vitronectin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shinoura, Nobusada</creatorcontrib><creatorcontrib>Heffelfinger, Sue C.</creatorcontrib><creatorcontrib>Miller, Maryann</creatorcontrib><creatorcontrib>Shamraj, Olga I.</creatorcontrib><creatorcontrib>Miura, Nam-Ho C.</creatorcontrib><creatorcontrib>Larson, Jeffrey J.</creatorcontrib><creatorcontrib>DeTribolet, Nicolet</creatorcontrib><creatorcontrib>Warnick, Ronald E.</creatorcontrib><creatorcontrib>Tew, John J.</creatorcontrib><creatorcontrib>Menon, Anil G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shinoura, Nobusada</au><au>Heffelfinger, Sue C.</au><au>Miller, Maryann</au><au>Shamraj, Olga I.</au><au>Miura, Nam-Ho C.</au><au>Larson, Jeffrey J.</au><au>DeTribolet, Nicolet</au><au>Warnick, Ronald E.</au><au>Tew, John J.</au><au>Menon, Anil G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RNA expression of complement regulatory proteins in human brain tumors</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>1994-11-11</date><risdate>1994</risdate><volume>86</volume><issue>2</issue><spage>143</spage><epage>149</epage><pages>143-149</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>The expression of complement regulatory proteins (CRP) on the surface of neoplastic cells has been proposed as a mechanism by which these cells evade immune surveillance. We have examined the RNA expression of the genes that encode 5 kinds of CRP in various human brain tumors to determine whether CRP expression might play a role in the malignant progression of these tumors. The benign and atypical meningiomas, and the astrocytomas showed high expression of SP-40,40, low expression of CD59, and barely detectable expression of CD46, CD55 and S-protein. The benign and atypical menigiomas showed significantly greater expression of SP-40,40 at the RNA level when compared to malignant meningiomas. This study describes the mRNA expression of meningiomas, astrocytomas, tumor cell lines and normal human tissues.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>7526972</pmid><doi>10.1016/0304-3835(94)90072-8</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-3835
ispartof Cancer letters, 1994-11, Vol.86 (2), p.143-149
issn 0304-3835
1872-7980
language eng
recordid cdi_proquest_miscellaneous_76856748
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antigens, CD - genetics
Astrocytoma - genetics
Base Sequence
Biological and medical sciences
Brain Neoplasms - genetics
Brain tumor
CD55 Antigens
CD59
CD59 Antigens
Clusterin
Complement Inactivator Proteins - genetics
Complement regulatory protein
Glycoproteins
Humans
Medical sciences
Membrane Cofactor Protein
Membrane Glycoproteins - genetics
Meningioma - genetics
Molecular Chaperones
Molecular Sequence Data
Neurology
RNA - analysis
SP40,40
Tumor Cells, Cultured
Tumors of the nervous system. Phacomatoses
Vitronectin
title RNA expression of complement regulatory proteins in human brain tumors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T23%3A47%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RNA%20expression%20of%20complement%20regulatory%20proteins%20in%20human%20brain%20tumors&rft.jtitle=Cancer%20letters&rft.au=Shinoura,%20Nobusada&rft.date=1994-11-11&rft.volume=86&rft.issue=2&rft.spage=143&rft.epage=149&rft.pages=143-149&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/0304-3835(94)90072-8&rft_dat=%3Cproquest_cross%3E76856748%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76856748&rft_id=info:pmid/7526972&rft_els_id=0304383594900728&rfr_iscdi=true